Glycogen synthase kinase 3 drives thymocyte egress by suppressing β-catenin activation of Akt

Chenfeng Liu1, Lei Ma1, Yuxuan Wang1

  • 1State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, China.

Science Advances
|October 8, 2021
PubMed

Insights

Glycogen synthase kinase 3 (GSK3) is crucial for thymocyte egress. Inhibiting GSK3 impairs T cell exit from the thymus by affecting β-catenin signaling and downstream pathways.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Thymocyte emigration is essential for adaptive immunity.
  • Molecular mechanisms regulating thymocyte egress are not fully elucidated.

Purpose of the Study:

  • To investigate the role of glycogen synthase kinase 3 (GSK3) in thymocyte emigration.
  • To identify molecular pathways involved in GSK3-mediated thymocyte egress.

Main Methods:

  • T cell-specific ablation of GSK3 in mice.
  • Analysis of β-catenin localization and activity.
  • Assessment of Akt, Foxo1, Klf2, and S1P1 expression.
  • Genetic and viral rescue experiments.

Main Results:

  • GSK3 deficiency severely impaired thymocyte egress.
  • GSK3 ablation caused cytoplasmic accumulation and nuclear exclusion of β-catenin.
  • Cytoplasmic β-catenin activated Akt, leading to Foxo1 degradation and reduced Klf2/S1P1 expression.
  • Genetic interventions targeting β-catenin, Akt, or Foxo1 restored thymocyte emigration.

Conclusions:

  • GSK3 plays a critical role in regulating thymocyte emigration.
  • A novel cytoplasmic function of β-catenin, independent of transcriptional activity, is identified in thymocyte egress.
  • GSK3 controls thymocyte exit through a pathway involving β-catenin, Akt, and Foxo1.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
13.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K